JPH06311891A - Production of trehalose - Google Patents
Production of trehaloseInfo
- Publication number
- JPH06311891A JPH06311891A JP9997493A JP9997493A JPH06311891A JP H06311891 A JPH06311891 A JP H06311891A JP 9997493 A JP9997493 A JP 9997493A JP 9997493 A JP9997493 A JP 9997493A JP H06311891 A JPH06311891 A JP H06311891A
- Authority
- JP
- Japan
- Prior art keywords
- trehalose
- sucrose
- carbon source
- sugar
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 title claims abstract description 59
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 title claims abstract description 59
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 title claims abstract description 58
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 229930006000 Sucrose Natural products 0.000 claims abstract description 29
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 29
- 239000005720 sucrose Substances 0.000 claims abstract description 28
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 23
- 235000000346 sugar Nutrition 0.000 claims abstract description 23
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 21
- 238000012258 culturing Methods 0.000 claims abstract description 20
- 239000003782 beta lactam antibiotic agent Substances 0.000 claims abstract description 9
- 239000002132 β-lactam antibiotic Substances 0.000 claims abstract description 9
- 229940124586 β-lactam antibiotics Drugs 0.000 claims abstract description 9
- 244000005700 microbiome Species 0.000 claims description 15
- 239000013589 supplement Substances 0.000 claims description 9
- 241000186254 coryneform bacterium Species 0.000 claims description 7
- 230000003698 anagen phase Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 13
- 230000000813 microbial effect Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 241000186031 Corynebacteriaceae Species 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 description 23
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 11
- 239000002609 medium Substances 0.000 description 9
- 229940056360 penicillin g Drugs 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 235000013379 molasses Nutrition 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 241000186146 Brevibacterium Species 0.000 description 3
- 241000186216 Corynebacterium Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000187654 Nocardia Species 0.000 description 3
- 241001361634 Rhizoctonia Species 0.000 description 3
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 241000186063 Arthrobacter Species 0.000 description 2
- 241000186226 Corynebacterium glutamicum Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241000144155 Microbacterium ammoniaphilum Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- FGNPLIQZJCYWLE-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;sulfuric acid Chemical compound OS(O)(=O)=O.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO FGNPLIQZJCYWLE-BTVCFUMJSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 108010074725 Alpha,alpha-trehalose phosphorylase Proteins 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010057899 Maltose phosphorylase Proteins 0.000 description 1
- 241001467578 Microbacterium Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 229930195708 Penicillin V Natural products 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- CZTQZXZIADLWOZ-CRAIPNDOSA-N cefaloridine Chemical compound O=C([C@@H](NC(=O)CC=1SC=CC=1)[C@H]1SC2)N1C(C(=O)[O-])=C2C[N+]1=CC=CC=C1 CZTQZXZIADLWOZ-CRAIPNDOSA-N 0.000 description 1
- 229960003866 cefaloridine Drugs 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940056367 penicillin v Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
- -1 plants Natural products 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、トレハロースを生産す
る能力を有するコリネ型細菌に属する微生物を培養して
トレハロースを生産させるに際し、補糖用の炭素源とし
て蔗糖を用いて培養してなるトレハロースの製造方法。TECHNICAL FIELD The present invention relates to a trehalose obtained by culturing a microorganism belonging to a coryneform bacterium having an ability to produce trehalose to produce trehalose, using sucrose as a carbon source for supplement sugar. Manufacturing method.
【0002】[0002]
【従来の技術】トレハロースは植物、昆虫、酵母、カ
ビ、海藻等の天然物に広く分布する二糖類(α−D−グ
ルコピラノシル−α−D−グルコピラノサイド)であ
る。従来トレハロースを得るには抽出法、酵素法、培養
法の3種類が知られている。BACKGROUND OF THE INVENTION Trehalose is a disaccharide (α-D-glucopyranosyl-α-D-glucopyranoside) widely distributed in natural products such as plants, insects, yeasts, molds and seaweeds. Conventionally, three types of extraction methods, enzyme methods, and culture methods are known to obtain trehalose.
【0003】抽出法としては、酵母菌体から抽出する方
法(農化、27、12(1953))、(J.Am.C
he.Soc.72、2059(1950))が知られ
ているが、トレハロースの生産量は、菌体量と菌体内ト
レハロース含量に制限されるため、充分な生産量が得ら
れていない。酵素法としては、マルトースを基質とし
て、マルトースホスホリラーゼとトレハロースホスホリ
ラーゼを用いて生成する方法(特開昭58−21669
5号公報)が知られているが、酵素の調整が困難であり
コストも要する。As the extraction method, a method of extracting from yeast cells (Nagaka, 27 , 12 (1953)), (J. Am. C
he. Soc. 72 , 2059 (1950)), but the amount of trehalose produced is not sufficient because the amount of trehalose is limited by the amount of microbial cells and the trehalose content in the cells. As an enzymatic method, maltose is used as a substrate and maltose phosphorylase and trehalose phosphorylase are used to produce the enzyme (Japanese Patent Laid-Open No. 58-21669).
No. 5) is known, but it is difficult to adjust the enzyme and it requires a cost.
【0004】また培養法としては、炭化水素資化性菌で
あるアースロバクター・パラフィネウス(Arthro
bactor・paraffineus)KY4303
による、炭化水素であるn−アルカン、具体的には10
%のn−パラフィンを炭素源とする培養による方法(A
gric.Biol.Chem.33(2)、190、
1969)、ノカルディア属に属する微生物の培養によ
る方法(特開昭50−154485号公報)及びリゾク
トニア属、スクレロチウム属に属する微生物の培養によ
る方法(特開平3−130084号公報)等が知られて
いる。しかしながら、アースロバクター・パラフィネウ
スKY4303によるトレハロースの製造においては、
炭素源として用いるn−アルカンが食品や医薬品への安
全性に問題を有する。またノカルディア属に属する微生
物のトレハロース生産能は極めて低い欠点を有するもの
であった。さらに、リゾクトニア属やスクレロチウム属
に属する生産菌は、植物病原菌であり、培養時間が約1
週間と長時間を要するものである。さらにまた、ノカル
ディア属やリゾクトニア属、スクレロチウム属等の生産
菌は、いずれも菌体内にトレハロースを蓄積するもの
で、そのためトレハロースを単離するには菌体内から抽
出するなど、煩雑な操作が必要になったり、大規模な設
備や多くのエネルギーが必要であったりする。As a culture method, Arthrobacter parafineus (Arthro), which is a hydrocarbon-assimilating bacterium, is used.
vector / paraffinine) KY4303
A hydrocarbon n-alkane, specifically 10
% By n-paraffin as a carbon source
gric. Biol. Chem. 33 (2), 190,
1969), a method of culturing a microorganism belonging to the genus Nocardia (Japanese Patent Laid-Open No. 50-154485), a method of culturing a microorganism belonging to the genus Rhizoctonia and the genus Sclerotium (Japanese Patent Laid-Open No. 130084), and the like. There is. However, in the production of trehalose by Arthrobacter parafineus KY4303,
The n-alkane used as a carbon source has a problem in safety for foods and pharmaceuticals. In addition, the microorganisms belonging to the genus Nocardia have a very low trehalose-producing ability. Furthermore, the production strains belonging to the genus Rhizoctonia and the genus Sclerotium are plant pathogens, and the culture time is about 1
It takes a week and a long time. Furthermore, the production bacteria of the genus Nocardia, Rhizoctonia, Sclerotium, etc. all accumulate trehalose in the microbial cells, so complicated procedures such as extraction from the microbial cells are required to isolate trehalose. Or require large-scale equipment and a lot of energy.
【0005】従って、安価にしかも大量にトレハロース
を生産する方法はまだ確立されていないのが実状であ
る。Therefore, in reality, a method for inexpensively producing a large amount of trehalose has not yet been established.
【0006】[0006]
【発明が解決しようとする課題】本発明は、トレハロー
ス生産能を有する微生物を培養して工業的有利にトレハ
ロースを製造する方法を提供しようとするものである。DISCLOSURE OF THE INVENTION The present invention is intended to provide a method for industrially advantageously producing trehalose by culturing a microorganism capable of producing trehalose.
【0007】[0007]
【課題を解決するための手段】本発明者らは、トレハロ
ースの製造法について鋭意研究した結果、トレハロース
生産能を有するコリネ型細菌に属する微生物を培養して
トレハロースを生産させるに際して、補糖用の炭素源と
して蔗糖を用いることにより、トレハロースを菌体外に
分泌するとともに、トレハロースの生産能が良好となる
ことを見いだした。さらに、この培養において、培養中
にβ−ラクタム抗生物質を加え、補糖として蔗糖を添加
することで、よりトレハロースの生産が改善されること
を見いだした。Means for Solving the Problems As a result of earnest studies on a method for producing trehalose, the present inventors have found that when trehalose is produced by culturing a microorganism belonging to a coryneform bacterium capable of producing trehalose, trehalose is produced. It was found that by using sucrose as a carbon source, trehalose is secreted outside the cells and the trehalose-producing ability is improved. Furthermore, in this culture, it was found that the trehalose production was further improved by adding the β-lactam antibiotic during the culture and adding sucrose as a supplement sugar.
【0008】本発明は上記の知見に基づいて完成された
もので、トレハロースを生産する能力を有するコリネ型
細菌に属する微生物を培養してトレハロースを生産させ
るに際し、補糖用の炭素源として蔗糖を用いて培養する
ことを特徴とするトレハロースの製造法であり、好まし
くはその培養においてβ−ラクタム抗生物質を添加し、
補糖用の炭素源として蔗糖を用いて培養することを特徴
とするトレハロースの製造法である。The present invention has been completed based on the above findings, and when culturing a microorganism belonging to a coryneform bacterium having an ability to produce trehalose to produce trehalose, sucrose is used as a carbon source for supplement sugar. A method for producing trehalose, which comprises culturing using, preferably adding β-lactam antibiotic in the culture,
A method for producing trehalose, which comprises culturing using sucrose as a carbon source for supplement sugar.
【0009】まず、本発明に用いるトレハロース生産能
を有するコリネ型細菌に属する微生物としては、コリネ
バクテリウム属、ブレビバクテリウム属、ミクロバクテ
リウム属、ミクロコッカス属に属する菌株、及びこれら
の変異株のトレハロース生産能を有するものがあげられ
る。例えば、コリネバクテリウム・メラセコラ(Cor
ynebacterium・melassecola)
285株(ATCC17965)、ブレビバクテリウム
・ディバリカツム(Brevibacterium・d
ivaricatum、NRRL B−2312)、ミ
クロバクテリウム・アンモニアフィラム(Microb
acterium・ammoniaphilum、AT
CC 15354)、ミクロコッカス・グルタミカス
(Micrococcus・glutamicus、A
TCC 14619)などが挙げられる。First, as microorganisms belonging to the coryneform bacterium having trehalose-producing ability used in the present invention, strains belonging to the genera Corynebacterium, Brevibacterium, Microbacterium, Micrococcus, and mutants thereof , Which has the trehalose-producing ability. For example, Corynebacterium meracecola (Cor
ynebacterium / melassecola)
285 strain (ATCC17965), Brevibacterium d.
ivaricatum, NRRL B-2312), Microbacterium ammoniaphilum (Microb
bacterium, ammoniaphilum, AT
CC 15354), Micrococcus glutamicus, A
TCC 14619) and the like.
【0010】上記微生物の培養に用いられる培地は、資
化可能な炭素源と通常の窒素源、無機塩及び微量の栄養
素を含有する培地である。本培養の始発培地における資
化可能な炭素源としては、例えばブドウ糖、果糖、麦芽
糖、蔗糖、酢酸、糖蜜、廃糖蜜、その他を単独または混
合して用いることが出来る。好ましくは、安価でしかも
ビオチン等の栄養素を含有する糖蜜または廃糖蜜であ
り、これは蔗糖濃度として1〜10%、好ましくは5〜
7%になるように添加して用いるもので、この始発培地
における糖濃度が10%以上になると、その糖による浸
透圧により、用いる微生物の培養が阻害される。The medium used for culturing the above-mentioned microorganism is a medium containing an assimilable carbon source, an ordinary nitrogen source, an inorganic salt and a trace amount of nutrients. As the assimilable carbon source in the initial culture medium of the main culture, for example, glucose, fructose, maltose, sucrose, acetic acid, molasses, molasses, etc. can be used alone or in combination. Molasses or molasses that is inexpensive and contains nutrients such as biotin is preferable as the sucrose concentration is 1 to 10%, preferably 5 to
It is used by adding 7% so that when the sugar concentration in this starting medium becomes 10% or more, the osmotic pressure of the sugar inhibits the culture of the microorganism to be used.
【0011】培地の窒素源としては、アンモニア、硫
安、塩安、硝安、尿素、ペプトン、肉エキス、酵母エキ
ス、コーンスティープリカー、カザミノ酸、その他を単
独または混合して用いることが出来る。無機塩として
は、リン酸、リン酸一水素カリウム、リン酸二水素カリ
ウム、硫酸マグネシウム等が用いられ、例えば5μg/
L以上のビオチンや100μg/L以上のサイアミン等
の各種ビタミン等の栄養素を培地に添加しても良い。As the nitrogen source of the medium, ammonia, ammonium sulfate, ammonium salt, ammonium nitrate, urea, peptone, meat extract, yeast extract, corn steep liquor, casamino acid, and the like can be used alone or in combination. As the inorganic salt, phosphoric acid, potassium monohydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate or the like is used, and for example, 5 μg /
Nutrients such as L or more biotin and 100 μg / L or more thiamine or other various vitamins may be added to the medium.
【0012】培養は通気攪拌、振盪等の好気的条件下で
行い、培養中のpHは5〜10、好ましくは7付近であ
り、その調節は酸またはアルカリを添加して行われる。
培養温度は20〜40℃、培養期間は12〜60時間、
好ましくは24〜40時間である。本発明における補糖
とは、対数増殖期の中期以降に炭素源を連続的叉は間欠
的に追加することであり、補糖用の炭素源として蔗糖を
用いることである。またこの補糖用としての蔗糖の添加
量は、培養液中の蔗糖の残糖量が1〜3%の濃度を維持
する量として添加する。Culturing is carried out under aerobic conditions such as aeration and shaking, and the pH during cultivation is 5 to 10, preferably around 7, and the adjustment is carried out by adding acid or alkali.
The culturing temperature is 20 to 40 ° C., the culturing period is 12 to 60 hours,
It is preferably 24 to 40 hours. The term "complementary sugar" in the present invention means to add a carbon source continuously or intermittently after the middle stage of the logarithmic growth phase, and to use sucrose as a carbon source for complementing sugar. The amount of sucrose used for supplementing sugar is such that the residual sugar amount of sucrose in the culture solution maintains a concentration of 1 to 3%.
【0013】さらに本発明におけるβ−ラクタム抗生物
質の添加において、その添加の時期としては菌体量を分
光光度計を用いたOD値から算出し、このOD値に基ず
く対数増殖期であれば良い。好ましくは培養開始後5〜
10時間目の対数増殖期の中期に添加するのが良く、添
加量は最終濃度として0.1〜100μg/ml、好ま
しくは0.5〜10μg/mlである。このようにして
用いられるβ−ラクタム抗生物質としては、例えばペニ
シリンG、ペニシリンV、アンピシリンなどのペニシリ
ン系やセファレキシン、セファロリジンなどのセファロ
スポリン系のものが挙げられ、適宜可溶性塩として用い
ることが出来る。β−ラクタム抗生物質を添加すること
によって、用いる微生物の細胞壁合成が阻害される為、
トレハロースが菌体外に分泌され、培地中にトレハロー
スが高濃度蓄積されることになる。Further, in the addition of the β-lactam antibiotic in the present invention, the amount of bacterial cells is calculated from the OD value using a spectrophotometer as the timing of the addition, and if the logarithmic growth phase is based on this OD value. good. 5 to 5 after the start of culture
It is advisable to add it in the middle phase of the 10th hour logarithmic growth phase, and the addition amount is 0.1 to 100 μg / ml, preferably 0.5 to 10 μg / ml as the final concentration. Examples of β-lactam antibiotics used in this manner include penicillin-based compounds such as penicillin G, penicillin V, and ampicillin, and cephalosporin-based compounds such as cephalexin and cephaloridine, which are appropriately used as soluble salts. I can. Addition of β-lactam antibiotics inhibits cell wall synthesis of the microorganism used,
Trehalose is secreted outside the cells, and trehalose accumulates in the medium at a high concentration.
【0014】この様に菌体外に生産されたトレハロース
は、公知の方法で分離精製することが出来る。分離精製
の方法としては、イオン交換カラムを通して、イオン性
物質を除去した後、活性炭(粒状炭)のカラムに通過さ
せ、トレハロースを吸着させる。このカラムからトレハ
ロースをメタノール等の適当な溶媒で溶出し、溶出液を
濃縮する。得られた残渣にエタノールを加えて、低温で
静置することにより、精製されたトレハロースを得るこ
とが出来る。The trehalose thus produced outside the cells can be separated and purified by a known method. As a method of separation and purification, after removing an ionic substance through an ion exchange column, the trehalose is adsorbed by passing through an activated carbon (granular carbon) column. Trehalose is eluted from this column with a suitable solvent such as methanol, and the eluate is concentrated. Purified trehalose can be obtained by adding ethanol to the obtained residue and allowing it to stand at a low temperature.
【0015】[0015]
【実施例】次に実施例をあげて本発明をさらに具体的に
説明するが、本発明はここに示した例に限定されるもの
ではない。トレハロースの定量は、以下に示す条件下、
高速液体クロマトグラフィー法によって行った。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to the examples shown here. The quantification of trehalose was carried out under the following conditions:
It was performed by a high performance liquid chromatography method.
【0016】〔高速液体クロマトグラフィー(HPL
C)測定条件〕 使用機器:LC−800システム(日本分光) カラム:TSK−GEL AMIDE80(東ソー) 流速:0.8ml/分 移動相:65%アセトニトリル 検出器:示差屈折計 保持時間:トレハロース:10.9分[High Performance Liquid Chromatography (HPL
C) Measurement conditions] Equipment used: LC-800 system (JASCO) Column: TSK-GEL AMIDE80 (Tosoh) Flow rate: 0.8 ml / min Mobile phase: 65% acetonitrile Detector: Differential refractometer Retention time: Trehalose: 10 .9 minutes
【0017】[0017]
【実施例1〜2、比較例1〜4】シード培地(廃糖蜜
(蔗糖として4%になるように添加)、MgSO4 ・7
H 2 O 0.05%、H3 PO4 0.15%、尿素
0.8%、殺菌前にpHは7.0にアンモニア水で調整
する)100mlを500ml容三角フラスコに分注
し、120℃、20分間滅菌した後、コリネバクテリウ
ム・メラセコラ 285株(ATCC 17965)を
植菌し、32℃で16時間振盪培養を行った。Examples 1-2, Comparative Examples 1-4 Seed medium (molasses molasses
(Added as 4% sucrose), MgSOFour・ 7
H 2O 0.05%, H3POFour0.15%, urea
0.8%, pH adjusted to 7.0 before sterilization with ammonia water
Dispense 100 ml into a 500 ml Erlenmeyer flask
And sterilize at 120 ° C for 20 minutes, then
Mu Melasecola 285 strain (ATCC 17965)
The cells were inoculated and cultured with shaking at 32 ° C. for 16 hours.
【0018】次に、本培養用の始発培地(廃糖蜜(蔗糖
として7%になるように添加)、MgSO4 ・7H2 O
0.05%、H3 PO4 0.15%、尿素 1%、殺
菌前にpHは5.6にNaOHで調整する)500ml
を1L容ジャーに仕込み、120℃、20分間滅菌した
後、上記前培養物の30mlを添加して回転数1500
rpm、通気量0.5L/分、34℃で培養した。培養
中のpHはアンモニア水により7.3付近に維持した。
消泡剤として、ポリアルキレングリコール系のものを使
用した。Next, a starting medium for main culture (waste molasses (added so as to be 7% as sucrose), MgSO 4 .7H 2 O)
0.05%, H 3 PO 4 0.15%, urea 1%, pH adjusted to 5.6 with NaOH before sterilization) 500 ml
Was placed in a 1 L jar and sterilized at 120 ° C. for 20 minutes, and then 30 ml of the above preculture was added to rotate at 1500 rpm.
Incubation was carried out at 34 ° C. with an rpm and aeration rate of 0.5 L / min. The pH during the culture was maintained at around 7.3 with aqueous ammonia.
As the defoaming agent, a polyalkylene glycol type was used.
【0019】培養開始後、8時間目にペニシリンG(カ
リウム塩)を最終濃度1μg/mlになるように添加し
た。また、蔗糖の補糖は培養開始後8時間目以降2時間
間隔で、残糖の蔗糖濃度が1〜3%になるように添加し
た。残糖の蔗糖濃度はKSシステム株式会社製のバイオ
センサーBF−2を用いて測定した。培養20時間目と
30時間目の、培養液当たりのトレハロース濃度を表1
に示した。Penicillin G (potassium salt) was added 8 hours after the start of culture so that the final concentration was 1 μg / ml. Further, the sucrose supplement sugar was added at an interval of 2 hours from the 8th hour after the start of the culture so that the sucrose concentration of the residual sugar was 1 to 3%. The sucrose concentration of residual sugar was measured using a biosensor BF-2 manufactured by KS System Co., Ltd. Table 1 shows the trehalose concentration per culture solution at 20 and 30 hours of culture.
It was shown to.
【0020】[0020]
【表1】 [Table 1]
【0021】実施例1は補糖用の炭素源として蔗糖を用
いた場合、実施例2は実施例1にペニシリンGを併用し
た場合、比較例1は実施例1の蔗糖の代わりにブドウ糖
を同量用いた場合、比較例2は比較例1においてペニシ
リンGを併用した場合、比較例3は実施例1の蔗糖の代
わりに果糖を同量用いた場合、比較例4は比較例3にお
いてペニシリンGを併用した場合である。In Example 1, sucrose was used as a carbon source for saccharose, in Example 2, penicillin G was used in combination with Example 1, and in Comparative Example 1, glucose was used instead of sucrose in Example 1. When used in an amount, Comparative Example 2 used together with Penicillin G in Comparative Example 1, Comparative Example 3 used the same amount of fructose instead of sucrose in Example 1, and Comparative Example 4 used Penicillin G in Comparative Example 3. This is the case when both are used together.
【0022】この表1の結果から明かなように、補糖用
の炭素源としては、蔗糖を用いた場合が最もトレハロー
スの生産性が良く、さらに培養中にペニシリンGを添加
することによって、トレハロースの生産量が著しく増加
した。補糖用の炭素源に蔗糖を用い、かつ培養時にペニ
シリンGを添加した場合の培養30時間目のトレハロー
ス生産量は3.2g/dlに達し、ブドウ糖を用いた場
合の4倍、果糖を用いた場合の10倍以上もの高い生産
量が得られた。As is clear from the results shown in Table 1, sucrose was the best as the carbon source for supplemental sugar, and the productivity of trehalose was the best, and the addition of penicillin G to the trehalose during the culturing further increased trehalose. Production has increased significantly. When sucrose was used as a carbon source for supplementing sugar and penicillin G was added at the time of culturing, the trehalose production amount at 30 hours of culture reached 3.2 g / dl, which was 4 times as high as fructose when glucose was used. The production amount was as high as 10 times as high as that of the conventional case.
【0023】[0023]
【実施例3】使用菌株がブレビバクテリウム・ディバリ
カツム(NRRL B−2312)、ミクロバクテリウ
ム・アンモニアフィラム(ATCC 15354)、ミ
クロコッカス・グルタミカス(ATCC 14619)
である以外、シード用の培地、培養の仕方及び本培養
は、実施例1〜2と同様に行った。Example 3 Strains used are Brevibacterium dibaricatum (NRRL B-2312), Microbacterium ammoniaphilum (ATCC 15354), and Micrococcus glutamicus (ATCC 14619).
Other than the above, the seed medium, the culturing method, and the main culturing were performed in the same manner as in Examples 1 and 2.
【0024】この結果を下記表2に示したが、各コリネ
型細菌に属するトレハロース生産能を有する微生物を培
養する際においても、補糖用の炭素源として蔗糖を用い
ることによりトレハロースが菌体外に生産されるととも
に、ペニシリンGを添加することによって、トレハロー
スがさらに著量分泌されることが明らかになった。The results are shown in Table 2 below. Even when culturing a microorganism belonging to each coryneform bacterium and having the ability to produce trehalose, trehalose was isolated from the outside of the cell by using sucrose as a carbon source for supplement sugar. It was revealed that trehalose was secreted in an even more significant amount by the addition of penicillin G while being produced in E. coli.
【0025】[0025]
【表2】 [Table 2]
【0026】[0026]
【発明の効果】本発明は、トレハロース生産能を有する
微生物を培養して、工業的有利にトレハロースを製造す
る方法を提供するものであり、コリネ型細菌に属する微
生物をを生産菌として用い、補糖用の炭素源として蔗糖
を用い、より好適には培養中にβ−ラクタム抗生物質を
添加することにより2〜10倍以上の多量のトレハロー
スが菌体外に分泌されて、工業的有利にトレハロースを
製造することが出来る。INDUSTRIAL APPLICABILITY The present invention provides a method for industrially advantageously producing trehalose by culturing a microorganism capable of producing trehalose. Using a microorganism belonging to a coryneform bacterium as a producing bacterium, By using sucrose as a carbon source for sugar, and more preferably by adding a β-lactam antibiotic during the culture, a large amount of trehalose of 2 to 10 times or more is secreted outside the cells, and trehalose is industrially advantageous. Can be manufactured.
Claims (4)
リネ型細菌に属する微生物を培養してトレハロースを生
産させるに際し、補糖用の炭素源として蔗糖を用いて培
養することを特徴とするトレハロースの製造方法。1. A method for producing trehalose, which comprises culturing a microorganism belonging to a coryneform bacterium having an ability to produce trehalose to produce trehalose, using sucrose as a carbon source for supplement sugar. .
が、蔗糖の残糖量として1〜3%に維持することからな
る請求項1記載のトレハロースの製造方法。2. The method for producing trehalose according to claim 1, wherein the added amount of sucrose as a carbon source for supplement sugar is maintained at 1 to 3% as the residual sugar amount of sucrose.
添加し、補糖用の炭素源として蔗糖を用いて培養してな
る請求項1記載のトレハロースの製造方法。3. The method for producing trehalose according to claim 1, wherein the β-lactam antibiotic is added in the culture, and the culture is performed using sucrose as a carbon source for supplement sugar.
増殖期であり、添加濃度が0.1〜100μg/mlで
ある請求項3記載のトレハロースの製造方法。4. The method for producing trehalose according to claim 3, wherein the β-lactam antibiotic is added in the logarithmic growth phase, and the added concentration is 0.1 to 100 μg / ml.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9997493A JPH06311891A (en) | 1993-04-27 | 1993-04-27 | Production of trehalose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9997493A JPH06311891A (en) | 1993-04-27 | 1993-04-27 | Production of trehalose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06311891A true JPH06311891A (en) | 1994-11-08 |
Family
ID=14261643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9997493A Pending JPH06311891A (en) | 1993-04-27 | 1993-04-27 | Production of trehalose |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH06311891A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013520196A (en) * | 2010-02-25 | 2013-06-06 | コルゲート・パーモリブ・カンパニー | Process for producing arginine using Corynebacterium glutamicum ATCC 21831 or Corynebacterium glutamicum ATCC 21493 in fermentation medium containing Cassava bagasse or jackfruit seed as a carbon source |
| JP2015198662A (en) * | 2015-06-01 | 2015-11-12 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | Process for producing arginine using corynebacterium glutamicum atcc21831 or corynebacterium glutamicum atcc21493 in fermentation medium containing cassava bagasse, or jackfruit seeds as carbon source |
-
1993
- 1993-04-27 JP JP9997493A patent/JPH06311891A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013520196A (en) * | 2010-02-25 | 2013-06-06 | コルゲート・パーモリブ・カンパニー | Process for producing arginine using Corynebacterium glutamicum ATCC 21831 or Corynebacterium glutamicum ATCC 21493 in fermentation medium containing Cassava bagasse or jackfruit seed as a carbon source |
| US9150892B2 (en) | 2010-02-25 | 2015-10-06 | Colgate-Palmolive Company | Process of producing arginine employing Corynebacterium glutamicum ATCC 21831 or Corynebacterium glutamicum ATCC 21493 in an afermantation medium comprising cassava bagasse or jackfruit seed as a carbon source |
| JP2015198662A (en) * | 2015-06-01 | 2015-11-12 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | Process for producing arginine using corynebacterium glutamicum atcc21831 or corynebacterium glutamicum atcc21493 in fermentation medium containing cassava bagasse, or jackfruit seeds as carbon source |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5378616A (en) | Mutant Escherichia coli capable of enhanced L-glutamic acid production by fermentation | |
| JPS61202694A (en) | Production of l-glutamine by fermentation method | |
| JP3008565B2 (en) | Method for producing L-glutamic acid by fermentation method | |
| US4444885A (en) | Process for producing L-proline by fermentation | |
| US6060267A (en) | Production of vitamin B6 with an enzyme-containing cell extract | |
| JPH06311891A (en) | Production of trehalose | |
| JPH05123178A (en) | Production of l-phenylalanine | |
| EP0950715A2 (en) | Enzymatic production of vitamin B6 | |
| US5869300A (en) | Method for producing L-glutamic acid by continuous fermentation | |
| EP0455170B1 (en) | Process for culturing microorganisms of the genus Pseudomonas and process for producing L-alanine using said microorganisms | |
| US4452889A (en) | Method of producing inosine and/or guanosine | |
| US3787288A (en) | Method for preparing alpha-aminobenzylpenicillin | |
| KR900005771B1 (en) | Process for the preparation of glutamic acid | |
| US3385762A (en) | Process for the production of l-tryptophan by fermentation | |
| JP3006907B2 (en) | Method for producing L-alanine by fermentation method | |
| KR0146493B1 (en) | Process for producing l-alanine by fermentation | |
| JPH027635B2 (en) | ||
| US3922202A (en) | Fermentation process | |
| US3902968A (en) | Fermentation process | |
| US3328261A (en) | Method for the fermentative production of 5-amino-4-imidazole carboxamide ribotide | |
| KR830001259B1 (en) | Method for producing L-glutamine by microorganisms | |
| KR890000538B1 (en) | Method for preparing 5'-inosinic acid by microorganism | |
| JPH029384A (en) | Production of l-glutamic acid by fermentation process | |
| JPS6170994A (en) | Method for producing cyclic (1→2)-β-D-glucan | |
| US3886044A (en) | Process of making cephamycin C by fermentation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050426 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050816 |